Jindal IVF - newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra

Jindal IVF Delivers Healthy Twins After Overcoming Obstructive Azoospermia and High-Risk Pregnancy

Newsmantra — Tue, 31 Dec 2024 10:03:29 +0000

– The IVF process, supported by PESA and ICSI, was designed to overcome the husband’s obstructive azoospermia and help the couple achieve a successful, healthy pregnancy

Chandigarh, 30th December 2024: Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF), has achieved another remarkable milestone in the field of reproductive medicine with the successful delivery of a baby from a complex case involving obstructive azoospermia and high-risk pregnancy. The journey began when a 35-year-old woman, along with her husband diagnosed with obstructive azoospermia, approached Jindal IVF for fertility treatment.

The couple had initially considered Intrauterine Insemination (IUI) with donor sperm, as the husband’s condition prevented sperm retrieval via natural means. However, after a thorough evaluation, which included all necessary diagnostic tests, the couple was counselled for IVF using the husband’s own sperm. Given the husband’s condition, sperm retrieval through Percutaneous Epididymal Sperm Aspiration (PESA) was identified as a viable option. PESA is a specialized procedure that allows sperm to be extracted directly from the epididymis in cases of obstructive azoospermia.

Under the expert guidance of Dr. Sheetal Jindal, Senior Consultant and IVF-PGT Specialist at Jindal IVF, the procedure proceeded with Intracytoplasmic Sperm Injection (ICSI) to fertilize the eggs retrieved from the wife’s ovaries. The wife’s ovarian reserve was determined to be average, and while multiple eggs were retrieved, only one high-quality embryo was formed after fertilization. Due to financial concerns, the couple chose not to proceed with embryo pooling, a decision made in light of the costs associated with additional embryos.

The embryo transfer was scheduled, and despite the initial odds, the single embryo transfer resulted in an unexpected outcome as the couple conceived twins. This rare phenomenon occurred as the single embryo, after implantation in the mother’s uterus, divided into two embryos, resulting in the birth of identical twins. This type of pregnancy is known as Monochorionic Diamniotic (MCDA) twins, where both fetuses share a single placenta, the common source of blood supply. While MCDA pregnancies can be associated with significant risks, including Twin-to-Twin Transfusion Syndrome (TTTS), the medical team at Jindal IVF closely monitored the pregnancy to ensure the best possible outcome for the twins.

Twin-to-Twin Transfusion Syndrome (TTTS), a potential complication of MCDA pregnancies, occurs when interconnecting blood vessels between the twins cause an unequal distribution of blood supply. This can lead to one twin becoming overhydrated and the other undernourished. In such cases, a critical intervention, such as laser photocoagulation, is required to cauterize the interconnecting blood vessels and equalize the blood flow. However, in this case, due to the severity of the situation, cord coagulation of one twin’s umbilical cord was performed to safeguard the health of the other twin.

After careful monitoring and treatment, the pregnancy progressed to 34 weeks, and the couple was overjoyed when they successfully delivered a single healthy baby, marking a major achievement for the medical team at Jindal IVF.

“We are immensely proud to have supported this couple through such a complex and challenging journey to parenthood. This case not only highlights the remarkable progress in reproductive technology but also the extraordinary resilience of our patients, whose trust in us made this success possible. The positive outcome of this pregnancy is a testament to our unwavering commitment to personalized care and the cutting-edge techniques we employ. It is a reminder of the profound impact that innovation in reproductive medicine can have in transforming lives and offering hope to families facing fertility challenges.” said Dr. Sheetal Jindal.

The parents, overjoyed with the outcome, expressed their gratitude towards Jindal IVF for the dedication, expertise, and care that led to the birth of their baby. “We are beyond thankful to Dr. Jindal and the entire Jindal IVF team for making our dream of parenthood come true. Despite the challenges we faced, their support was unwavering, and we are forever grateful for their efforts,” the couple shared.

Jindal IVF remains committed to delivering exceptional care and offering personalized solutions for couples facing infertility. With over 30 years of experience in Assisted Reproductive Technology, Jindal IVF continues to lead the way in transforming lives through innovation and compassionate care.

The post Jindal IVF Delivers Healthy Twins After Overcoming Obstructive Azoospermia and High-Risk Pregnancy appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

Jindal IVF Expands Fertility Care to Yamunanagar Through Strategic Partnership with Mittal Maternity and Nursing Home

Newsmantra — Thu, 21 Nov 2024 13:12:31 +0000

-Mittal Maternity and Nursing Home will handle initial patient screenings, consultations, and IVF stimulation treatments locally

-Patients need only travel to Jindal IVF, Chandigarh, for essential procedures such as Ovum Pickup (OPU) and Embryo Transfer (ET)

-This tie-up not only ensures convenience but also delivers the highest success rates in the field

Yamunanagar, 21st November 2024: Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF), has announced a strategic partnership with Mittal Maternity and Nursing Home, Yamunanagar, Haryana. This collaboration, in place since 2014, aims to bring Jindal IVF’s advanced fertility treatments closer to patients in Yamunanagar and nearby areas, providing them with convenient, top-tier care without the need for frequent travel.

The partnership ensures that initial screenings, consultations, and fertility stimulation treatments are managed at Mittal Maternity and Nursing Home. Patients are only required to visit Jindal IVF, Chandigarh, for Ovum Pick Up (OPU) and Embryo Transfer (ET), with post-procedure monitoring and stimulation continuing locally. With just two or three trips to Chandigarh, patients can now avail themselves of world-class fertility treatments while staying close to home. This tie-up not only ensures convenience but also delivers the highest success rates in the field, further solidifying the trust patients place in Jindal IVF.

Commenting on the partnership, Dr. Sheetal Jindal, Senior Consultant and IVF-PGT expert at Jindal IVF, said, “This partnership with Mittal Maternity and Nursing Home is an extension of our commitment to making advanced fertility care more accessible across Northern India. The collaboration brings together the strengths of both institutions to offer patients a seamless treatment experience. Patients can benefit from the expertise of one of the region’s most experienced IVF teams while avoiding the physical and emotional burden of extensive travel. Our consistent success rates stand as a testament to our dedication to clinical excellence, and we are proud to bring this level of care closer to patients in Yamunanagar.”

Dr. Manishi Mittal of Mittal Maternity and Nursing Home shared, “We are delighted to collaborate with Jindal IVF to bring the best fertility treatment options to our community. This partnership bridges the gap between local convenience and expert care, ensuring that couples can access top-notch fertility treatments without leaving the comfort of their hometown. For 34 years, we’ve been dedicated to providing quality medical care, and this partnership elevates our ability to support couples on their fertility journeys with the latest technologies and compassionate care. We are excited to see this collaboration transform lives and deliver on our vision to offer comprehensive, ethical, and cutting-edge reproductive care.”

Mittal Maternity and Nursing Home, located in Yamunanagar, has been a center of excellence in Endocrinology, Obstetrics, Gynecology, and Infertility for over three decades. Their comprehensive services include the management of reproductive disorders, diabetes, thyroid conditions, menstrual irregularities, and puberty-related issues. The hospital also boasts advanced laparoscopy and hysteroscopy facilities for minimally invasive surgeries, ensuring that patients receive high-quality care with minimal discomfort.

As part of their mission, they offer holistic solutions for diabetes and obesity through diet counseling, physical training, and medication. Their maternity services are among the best in the region, striving for continuous improvement and ensuring that every pregnancy is a healthy and fulfilling experience. With a registered ultrasound center offering specialized scans, including early pregnancy, fetal growth, and anomaly scans, Mittal Maternity and Nursing Home is a trusted name in reproductive healthcare, committed to compassionate, ethical treatment for all patients.

This tie-up follows Jindal IVF’s successful partnerships with Mandav Hospital in Mandi, Sai Hospital in Hamirpur, and Kullu Valley Hospital in Himachal Pradesh, further expanding their reach across Northern India and making IVF care more accessible to underserved regions.

The post Jindal IVF Expands Fertility Care to Yamunanagar Through Strategic Partnership with Mittal Maternity and Nursing Home appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.